Ye, Pingjiang <br/><br/>
Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Mar 2016 
 - 613-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-016-2979-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--genetics<br/>Antibiotics, Antineoplastic--pharmacology<br/>Cell Line<br/>Cell Line, Tumor<br/>Colon--cytology<br/>Colorectal Neoplasms--drug therapy<br/>Down-Regulation--genetics<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm--genetics<br/>Epithelial Cells--enzymology<br/>Gene Expression Regulation, Neoplastic<br/>Gene Knockdown Techniques<br/>Gene Silencing<br/>HCT116 Cells<br/>Histone Deacetylase 2--genetics<br/>Humans<br/>Multidrug Resistance-Associated Protein 2<br/>RNA, Small Interfering--genetics